tiprankstipranks
Trending News
More News >
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market

Cidara Therapeutics (CDTX) Income Statement

Compare
862 Followers

Cidara Therapeutics Income Statement

Last quarter (Q3 2025), Cidara Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Cidara Therapeutics's net income was $-83.23M. See Cidara Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.27M$ 23.28M$ 64.45M$ 49.57M$ 12.07M
Gross Profit
$ 1.27M$ -13.48M$ 64.45M$ -23.52M$ 12.07M
Operating Expenses
$ 177.38M$ 13.58M$ 97.95M$ 18.74M$ 83.92M
Depreciation and Amortization
$ 233.00K$ 112.00K$ 143.00K$ 189.00K$ 1.05M
EBITDA
$ -175.87M$ -26.95M$ -33.36M$ -42.07M$ -70.80M
Operating Income
$ -176.10M$ -27.06M$ -33.50M$ -42.26M$ -71.85M
Other Income/Expenses
$ 5.81M$ 2.00M$ 191.00K$ -212.00K$ -262.00K
Pretax Income
$ -170.29M$ -25.07M$ -33.31M$ -42.47M$ -72.11M
Net Income
$ -169.83M$ -22.93M$ -33.58M$ -42.47M$ -72.11M
Per Share Metrics
Basic EPS
$ -26.75$ -5.25$ -9.61$ -16.20$ -36.03
Diluted EPS
$ -26.75$ -5.25$ -9.61$ -16.19$ -36.03
Weighted Average Shares Outstanding
6.35M 4.37M 3.49M 2.62M 2.08M
Weighted Average Shares Outstanding (Diluted)
6.35M 4.37M 3.49M 2.62M 2.08M
Currency in USD

Cidara Therapeutics Earnings and Revenue History